Topical Finasteride vs. Oral Finasteride: Which Should You Choose?

Same drug, different delivery. Topical finasteride has been quietly reshaping the hair loss treatment landscape since 2022, offering what many men want most: comparable hair growth results with significantly lower systemic exposure. But is the trade-off really that clean?

We dug into the Phase III trial data, pharmacokinetic studies, and real-world pricing to give you a clear picture of how these two formulations stack up in 2026.

The Headline Numbers

Side-by-Side Comparison

How Topical Achieves Similar Results With Less Systemic Exposure

This seems counterintuitive — if topical finasteride reduces serum DHT by only 34.5% compared to oral's 55.6%, how does it produce comparable hair growth?

The answer lies in local concentration. When applied to the scalp, topical finasteride achieves high drug concentrations directly at the hair follicle, inhibiting the 5-alpha reductase enzyme right where it matters. It doesn't need to flood the entire bloodstream to reach your scalp. Think of it like putting eyedrops in your eyes instead of taking an oral medication for dry eyes — targeted delivery means you need far less total drug to achieve the same local effect.

The lower serum DHT reduction is actually the point. Less systemic DHT suppression means a lower likelihood of systemic side effects while still delivering therapeutic levels to the follicles.

The Side Effect Advantage

A 2020 Dermatologic Therapy study tracked sexual side effects over 12 months and found a meaningful difference: 1.1% of topical users reported sexual side effects compared to 2.7% of oral users. While both numbers are low, the difference is clinically notable — especially for men who are anxious about this risk.

A 2026 pharmacovigilance study by Gupta, published in a Wiley journal, analyzed adverse event reporting data and found that oral finasteride generated significantly more adverse event reports than topical formulations across all side effect categories. This is observational data (not a controlled trial), but it aligns with the pharmacokinetic rationale: less drug in the bloodstream means fewer systemic effects.

The Cost Trade-Off

This is where oral finasteride maintains a clear advantage. Generic oral finasteride is one of the cheapest prescription medications available:

Topical formulations are compounded medications — custom-mixed at specialty pharmacies — which makes them inherently more expensive than mass-manufactured generic pills. Platforms like Happy Head ($59–$149/mo) and others offer topical finasteride in combination with minoxidil and other active ingredients, which adds value but also cost.

For a detailed pricing breakdown across all telehealth platforms, see our finasteride pricing guide.

The FDA Warning on Compounded Topicals

In April 2025, the FDA issued an advisory noting 32 adverse events associated with compounded topical finasteride products. This is worth knowing about but requires context:

• 32 adverse events across millions of users represents an extremely low incidence rate
• Compounded medications are not subject to the same manufacturing standards as FDA-approved products — quality varies by pharmacy
• This underscores the importance of using reputable telehealth platforms that partner with licensed, accredited compounding pharmacies

Who Should Choose Which?

Oral finasteride makes sense if:

• You want maximum simplicity — one pill, once a day, done
• Budget is a primary concern (generic can be under $5/month)
• You're comfortable with the systemic side effect profile
• You want the formulation with 30 years of long-term safety data

Topical finasteride makes sense if:

• Sexual side effects are your primary concern
• You've tried oral finasteride and experienced side effects
• You want to combine finasteride + minoxidil in a single topical product
• You're willing to pay a premium for reduced systemic exposure
• You prefer a treatment that doesn't require swallowing a pill

The Bottom Line

Topical finasteride is a legitimate advancement in hair loss treatment. The Phase III data shows it delivers comparable hair growth results while exposing your body to a fraction of the systemic drug levels. For men worried about side effects, it's the closest thing to a best-of-both-worlds option currently available.

The trade-offs are cost (2–15× more expensive), convenience (daily scalp application vs. a pill), and the fact that it's compounded off-label rather than FDA-approved for hair loss specifically.

Either way, the critical decision isn't topical vs. oral — it's whether to start treatment at all. Both formulations work for the vast majority of men. The best version is the one you'll actually use consistently.